Adagio Medical Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on October 20, 2025. The Company is an emerging growth company incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The report addresses the closing of a previously announced private placement transaction.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of a corporate event rather than a financial performance report.
Material Changes
The primary material event reported is the closing of a private placement of securities. This transaction was previously announced on October 14, 2025, via a Securities Purchase Agreement with certain accredited investors. The closing was finalized on October 20, 2025.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the transaction closing. The press release detailing the closing is attached as Exhibit 99.1 but its specific terms are not summarized in the body of this 8-K.
Investor Verification Checklist
- Verify the total capital raised and the number of shares issued in the private placement by reviewing Exhibit 99.1 (Press Release).
- Confirm the identity of the accredited investors and any specific terms of the Securities Purchase Agreement.
- Check for any dilution impact on existing shareholders resulting from this issuance.
- Review the Company's most recent 10-Q or 10-K for baseline financial metrics not included in this 8-K.